PBM
LQD icon

Propel Bio Management’s iShares iBoxx $ Investment Grade Corporate Bond ETF LQD Stock Holding History

Propel Bio Management’s Portfolio LQD Stock Details LQD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,456
Closed -$485K – 27
2024
Q1 		$485K Hold
4,456
– – 0.28% 25
2023
Q4 		$493K Buy
+4,456
New +$464K 0.41% 28

Other funds holding LQD

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $3.01B AUM 7.86% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $5.29B AUM 8.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Financial Engines Advisors
Financial Engines Advisors Santa Clara, California $56.3B AUM 17.83% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NI
NYL Investors New York $261M AUM 5.93% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $52B AUM 24.53% 1-Year Est. Return

Propel Bio Management's LQD Position: Q2 2024 in Review

Propel Bio Management sold out of iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) in Q2 2024, closing a stake of 4,456 shares — an estimated $485K sold.

Propel Bio Management first reported a position in LQD in Q4 2023 and held it in 2 quarters. The position peaked at $493K in Q4 2023. 1,007 funds tracked by Wall St. Rank hold LQD as of Q2 2024.

  • Propel Bio Management reported no remaining iShares iBoxx $ Investment Grade Corporate Bond ETF position as of Q2 2024 after selling out during the quarter.
  • Propel Bio Management sold 4,456 iShares iBoxx $ Investment Grade Corporate Bond ETF shares in Q2 2024, an estimated $485K.
  • Propel Bio Management first reported a position in iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2023 and held it in 2 quarters.
  • Propel Bio Management's iShares iBoxx $ Investment Grade Corporate Bond ETF position peaked at $493K in Q4 2023.
  • 1,007 funds tracked by Wall St. Rank held iShares iBoxx $ Investment Grade Corporate Bond ETF as of Q2 2024.

Based on Propel Bio Management's 13F filing for Q2 2024, filed 12 Aug 2024.